1. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- Author
-
Clavien, Pa, Lesurtel, M, Bossuyt, Pm, Gores, Gj, Langer, B, Perrier, A, OLT for HCC Consensus Group Abecassis, M, Balabaud, C, Barritt, Gj, Belghiti, J, Bhoori, S, Bossuyt, P, Breitenstein, S, Broelsch, C, Bruix, J, Burra, Patrizia, Burroughs, A, Busuttil, R, Charlton, M, Cherqui, D, Colombo, Ml, D'Albuquerque, C, D'Alessandro, A, de Santibañez EJ, Dufour, F, Durand, F, Dutkowski, P, Duvoux, C, El Serag, H, Fan, St, Finn, Rs, Fisher, R, Forner, A, Freeman, R, Fung, J, Geier, A, Germani, G, Gores, G, Gouw, As, Grant, D, Greig, P, Gurusamy, K, Hanto, D, Heaton, N, Heim, M, Hemming, A, Hippen, B, Hisham, A, Hubscher, S, Ichida, T, Kahn, D, Kew, M, Kita, Y, Kiuchi, T, Klintmalm, Gb, Kneteman, N, Kojiro, M, Kudo, M, Lee, Jm, Lee, Sg, Lencioni, R, Lerut, J, Livraghi, T, Llovet, J, Lo, Cm, Lodge, P, Maccaughan, G, Madoff, D, Majno, P, Marcellin, P, Marrero, J, Mazzaferro, V, Mergental, H, Merle, P, Miksad, R, Mornex, F, Müllhaupt, B, Olthoff, K, Paradis, V, Pestalozzi, B, Pomfret, E, Poon, R, Porte, R, Prasad, Kr, Raptis, D, Roskams, T, Rossi, M, Samuel, D, Schlitt, H, Schwartz, M, Sexton Dobby AM, Shaked, A, Sherman, M, Siegler, M, Suh, Ks, Todo, S, Toso, C, Trevisani, F, Trotter, Jj, Valdecasas, Gj, Vauthey, N, Vilgrain, V, Villamil, F, Vonlanthen, R, Wald, C, Weber, A, Wiesner, R, Wright, L, Yao, F, Zheng, Ss, Zucman Rossi, J., P.A.Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gore, B. Langer, A. Perrier, on behalf of the OLT for HCC Consensus Group […, F. Trevisani, and …]
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Waiting Lists ,medicine.medical_treatment ,media_common.quotation_subject ,MEDLINE ,030230 surgery ,Liver transplantation ,Milan criteria ,Risk Assessment ,Article ,RECOMMENDATIONS ,03 medical and health sciences ,0302 clinical medicine ,Jury ,Risk Factors ,Liver Neoplasms/mortality/surgery ,medicine ,hepatocellular carcinoma ,liver transplantation ,Humans ,HEPATOCELLULAR CARCINOMA ,Hepatocellular/mortality/surgery ,Tissue Donors/supply & distribution ,media_common ,ddc:616 ,Evidence-Based Medicine ,business.industry ,Patient Selection ,Liver Neoplasms ,Carcinoma ,LIVER TRANSPLANTATION ,Evidence-based medicine ,medicine.disease ,Tissue Donors ,Neoadjuvant Therapy ,3. Good health ,Surgery ,Treatment Outcome ,Oncology ,Family medicine ,Donation ,Hepatocellular carcinoma ,Liver Transplantation/adverse effects/mortality/standards ,030211 gastroenterology & hepatology ,Working group ,business - Abstract
Although liver transplantation is a widely accepted treatment for hepatocellular carcinoma (HCC), much controversy remains and there is no generally accepted set of guidelines. An international consensus conference was held on Dec 2–4, 2010, in Zurich, Switzerland, with the aim of reviewing current practice regarding liver transplantation in patients with HCC and to develop internationally accepted statements and guidelines. The format of the conference was based on the Danish model. 19 working groups of experts prepared evidence-based reviews according to the Oxford classification, and drafted recommendations answering 19 specific questions. An independent jury of nine members was appointed to review these submissions and make final recommendations, after debates with the experts and audience at the conference. This report presents the final 37 statements and recommendations, covering assessment of candidates for liver transplantation, criteria for listing in cirrhotic and non-cirrhotic patients, role of tumour downstaging, management of patients on the waiting list, role of living donation, and post-transplant management.
- Published
- 2012
- Full Text
- View/download PDF